BioCentriq
Neeyav Shah is an experienced professional in the pharmaceutical industry, currently serving as a Senior Manager at BioCentriq since October 2022. Previously, Neeyav held multiple roles at Bristol Myers Squibb from July 2020 to October 2022, including Supervisor ECQ and Senior Validation Specialist. Prior experience includes positions at Celgene as a Validation Specialist, Hemispherx Biopharma as a Validation Specialist, and Amneal Pharmaceuticals as a Quality Assurance Auditor and Validation Engineer. Neeyav's career began as a Pharmacy Technician at Walmart and worked as a Production Intern at West-Ward Pharmaceuticals. Educational qualifications include a Master's degree in Pharmaceutical Manufacturing and Engineering from Stevens Institute of Technology and a Bachelor of Pharmacy degree from Bapuji Degree College.
This person is not in any teams
This person is not in any offices
BioCentriq
Established in 2019, BioCentriq is a full-service, New Jersey-based CDMO for cell and gene therapy, focusing on all stages of process development and clinical manufacturing. With over 90 scientists, engineers, analysts, and manufacturing specialists, we have the quality systems and infrastructure required to support the release of both autologous and allogeneic drug products. BioCentriq also specializes in viral vector process development and manufacturing with expertise in a variety of cell and vector types. Our 35,000 square feet of facilities includes four, soon to be five, ISO-7 certified GMP manufacturing suites, a fully equipped process development laboratory, quality control and analytical method development laboratories, and training facilities. We also operate the only McKinsey-owned Innovation & Learning Center designed to explore the application of industry 4.0, digital and lean manufacturing disciplines to life sciences.